The global Cell Culture Market is estimated to Growth Accelerated by Adoption of Single-Use Bioreactors
Cell culture is a process where living cells are grown under
controlled sterile laboratory conditions. Cell culture techniques enable
production of therapeutic proteins, vaccines, monoclonal antibodies and
diagnostic tests. Rising prevalence of chronic diseases and growing demand for
protein based drugs is driving need for increased cell culture capacity.
Additionally single-use bioreactors that eliminate challenges associated with clean-in-place
and sterilize-in-place processes are gaining rapid adoption in cell culture
production, as they offer increased flexibility and are less capital intensive
as compared to stainless-steel bioreactors.
The global Cell
Culture Market is estimated to be valued at US$ 19,198.0 Mn in 2023 and is
expected to exhibit a CAGR of 7.2% over the forecast period 2023 to 2030, as
highlighted in a new report published by Coherent Market Insights.
Market key trends:
The growing adoption of single-use bioreactors is a key trend in the cell
culture market. Single-use bioreactors are pre-sterilized and disposable
bioreactors used for cell culture production. They eliminate the need for
validating cleaning and sterilization processes required for reusable stainless
steel bioreactors. Additionally, single use bioreactors offer improved
flexibility as production can be stopped and restarted easily without the need
for cleaning validations. Their easy implementation and disposable nature
significantly reduces operational costs for cell culture manufacturers. As a
result, single-use bioreactors are rapidly gaining preference over conventional
reusable bioreactors, thereby driving growth of the overall cell culture market
during the forecast period.
Segment Analysis
The global cell culture market is divided into sub-segments based on product,
application, end-user and geography. Based on product, the market is segmented
into media, sera, reagents, and bioreactors/incubators. Among these, the media
segment currently dominates the market due to high demand for media and growth
factors as they form the base for cell cultures. The sera segment also has a
significant share due to widespread adoption of fetal bovine serum for
cell-line development and cell culturing processes.
Key Takeaways
The global cell culture market is expected to witness high growth during the
forecast period of 2023 to 2030. The global Cell Culture Market is estimated to
be valued at US$ 19,198.0 Mn in 2023 and is expected to exhibit a CAGR of 7.2%
over the forecast period 2023 to 2030.
Regional analysis related content comprises:
North America holds the largest share in the cell culture market mainly due to
extensive medical research and technological advancements in the region. The
presence of major players along with high healthcare expenditure and funding
for medical research further boost the market growth in North America. However,
Asia Pacific is projected to experience the highest growth during the forecast
period. This can be attributed to increasing prevalence of various chronic
diseases, improving healthcare infrastructure, and growing government support
for life science research in developing countries such as China and India.
Key players related content comprises:
Key players operating in the cell culture market include Corning Incorporated,
Merck KGaA, Sartorius AG, BioSpherix, Ltd., Cell Culture Company, LLC, Thermo
Fisher Scientific Inc., VWR International LLC, and Lonza. Among these, Thermo
Fisher Scientific Inc. and Merck KGaA hold a significant market share owing to
their broad product portfolio and strong global presence.

Comments
Post a Comment